News

FDA vaccine chief leaving agency after less than 3 months

The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
STAT3hOpinion

Vinay Prasad was not good for the FDA. But his ouster makes things worse

Vinay Prasad’s three-month tenure as one of the top officials at the Food and Drug Administration was bad for medicine. But ...
BioSpace4h

New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit

George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a ...
Amazon S3 on MSN4h

The story of Sarepta's Duchenne gene therapy

The last couple of weeks has been particularly distressing for Duchenne muscular dystrophy patients and their families. The ...

Prasad’s FDA exit may accelerate cell and gene therapy approvals

Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...
Devdiscourse5h

Vinay Prasad's Controversial Exit from the FDA

Vinay Prasad, appointed as FDA's top vaccine official, faced criticism and backlash during his short tenure. Controversies surrounded gene therapy safety and regulatory decisions affecting futures of ...

Senate confirms CDC director as top FDA official resigns under political pressure

In a 51–47 vote along party lines, the Senate confirmed Monarez as the director of the Centers for Disease Control and ...
PharmExec6h

Vinay Prasad’s FDA Departure Follows Controversy Over Drug Rejections

The FDA’s top vaccine and gene therapy official resigned amid heightened scrutiny over recent drug approval decisions and ...
The New York Sun7h

FDA’s Top Regulator Is Out Amid MAHA Backlash Over Blocking Access to a $3.2 Million Per Dose Therapy for Rare Disorder in Boys

Vinay Prasad, who came under fire from patient advocacy groups and Laura Loomer, is gone after less than three months on the ...
BioSpace7h

Exit Stage Right: With Prasad Out, Analysts Hope for More Traditional Replacement

As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more ...

US FDA's top vaccine official Vinay Prasad leaves agency after 3 months

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
STAT8h

Pharmalittle: We’re reading about Prasad leaving FDA, a pause on NIH spending, and much more

Vinay Prasad, a top FDA official, suddenly departed after a series of controversial decisions about a Duchenne gene therapy ...